Literature DB >> 10898518

Control of epithelial Na+ conductance by the cystic fibrosis transmembrane conductance regulator.

K Kunzelmann1, R Schreiber, R Nitschke, M Mall.   

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial Cl- channel expressed in luminal membranes of secretory and reabsorptive epithelia. CFTR plays a predominant role in both cAMP- and Ca2+-activated secretion of electrolytes. Although Ca2+-dependent Cl- channels exist independent of CFTR in the airway epithelium, their physiological significance remains to be determined. However, CFTR seems to be the only relevant Cl- conductance in the colonic epithelium. Apart from its secretory function, CFTR also has a task in regulating the reabsorption of electrolytes by controlling the activity of the epithelial Na+ channel, ENaC. Accordingly, defects in CFTR causing the disease cystic fibrosis (CF) lead to disturbances of both the secretion and absorption of electrolytes. Therefore, it is unclear what is pathophysiologically more important for the development of CF lung disease, the impaired secretion of Cl- or the enhanced reabsorption of Na+ and consecutive hyperabsorption of electrolytes. The mechanisms of how CFTR and ENaC interact are unknown. Previous work has given rise to several interesting working hypothesis, such as direct protein interaction or interaction via cytoskeletal proteins. Recent studies demonstrate the importance of the first nucleotide binding fold of CFTR, not only for the inhibition of ENaC but also for the interaction with other ion channels. Further studies are required to demonstrate whether regulation of other ion channels and membrane transport by CFTR occur by a common mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898518     DOI: 10.1007/s004240000255

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  32 in total

Review 1.  Towards a physiology of epithelial pathogens.

Authors:  I Cook; A Young
Journal:  Pflugers Arch       Date:  2001-11-01       Impact factor: 3.657

Review 2.  Molecular diversity and regulation of renal potassium channels.

Authors:  Steven C Hebert; Gary Desir; Gerhard Giebisch; Wenhui Wang
Journal:  Physiol Rev       Date:  2005-01       Impact factor: 37.312

Review 3.  Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC).

Authors:  Johannes Loffing; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2009-03-11       Impact factor: 3.657

Review 4.  Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart.

Authors:  Dayue Duan
Journal:  J Physiol       Date:  2009-01-26       Impact factor: 5.182

5.  Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice.

Authors:  Kelvin D MacDonald; Karen R McKenzie; Mark J Henderson; Charles E Hawkins; Neeraj Vij; Pamela L Zeitlin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-19       Impact factor: 5.464

Review 6.  CFTR and TNR-CFTR expression and function in the kidney.

Authors:  Jackson Souza-Menezes; Geórgia da Silva Feltran; Marcelo M Morales
Journal:  Biophys Rev       Date:  2014-05-07

Review 7.  CFTR structure and function: is there a role in the kidney?

Authors:  J Souza-Menezes; M M Morales
Journal:  Biophys Rev       Date:  2009-01-17

8.  Endolymphatic sodium homeostasis by extramacular epithelium of the saccule.

Authors:  Sung Huhn Kim; Daniel C Marcus
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

9.  Control of epithelial ion transport by Cl- and PDZ proteins.

Authors:  R Schreiber; A Boucherot; B Mürle; J Sun; K Kunzelmann
Journal:  J Membr Biol       Date:  2004-05-15       Impact factor: 1.843

10.  Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells.

Authors:  Ryan R McWilliams; Elizabeth Gidey; Laura Fouassier; Scott A Weed; R Brian Doctor
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.